NM_017415.3:c.1383G>A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_017415.3(KLHL3):​c.1383G>A​(p.Glu461Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.195 in 1,613,898 control chromosomes in the GnomAD database, including 32,448 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 2887 hom., cov: 33)
Exomes 𝑓: 0.20 ( 29561 hom. )

Consequence

KLHL3
NM_017415.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.972

Publications

19 publications found
Variant links:
Genes affected
KLHL3 (HGNC:6354): (kelch like family member 3) This gene is ubiquitously expressed and encodes a full-length protein which has an N-terminal BTB domain followed by a BACK domain and six kelch-like repeats in the C-terminus. These kelch-like repeats promote substrate ubiquitination of bound proteins via interaction of the BTB domain with the CUL3 (cullin 3) component of a cullin-RING E3 ubiquitin ligase (CRL) complex. Muatations in this gene cause pseudohypoaldosteronism type IID (PHA2D); a rare Mendelian syndrome featuring hypertension, hyperkalaemia and metabolic acidosis. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Mar 2012]
KLHL3 Gene-Disease associations (from GenCC):
  • pseudohypoaldosteronism type 2D
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 5-137634104-C-T is Benign according to our data. Variant chr5-137634104-C-T is described in ClinVar as Benign. ClinVar VariationId is 260807.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.972 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.392 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KLHL3NM_017415.3 linkc.1383G>A p.Glu461Glu synonymous_variant Exon 12 of 15 ENST00000309755.9 NP_059111.2 Q9UH77-1
KLHL3NM_001257194.1 linkc.1287G>A p.Glu429Glu synonymous_variant Exon 12 of 15 NP_001244123.1 Q9UH77-2
KLHL3NM_001257195.2 linkc.1137G>A p.Glu379Glu synonymous_variant Exon 10 of 13 NP_001244124.1 Q9UH77-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KLHL3ENST00000309755.9 linkc.1383G>A p.Glu461Glu synonymous_variant Exon 12 of 15 1 NM_017415.3 ENSP00000312397.4 Q9UH77-1

Frequencies

GnomAD3 genomes
AF:
0.178
AC:
27140
AN:
152106
Hom.:
2890
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0889
Gnomad AMI
AF:
0.0493
Gnomad AMR
AF:
0.229
Gnomad ASJ
AF:
0.180
Gnomad EAS
AF:
0.408
Gnomad SAS
AF:
0.249
Gnomad FIN
AF:
0.266
Gnomad MID
AF:
0.117
Gnomad NFE
AF:
0.188
Gnomad OTH
AF:
0.174
GnomAD2 exomes
AF:
0.221
AC:
55610
AN:
251166
AF XY:
0.219
show subpopulations
Gnomad AFR exome
AF:
0.0849
Gnomad AMR exome
AF:
0.276
Gnomad ASJ exome
AF:
0.178
Gnomad EAS exome
AF:
0.432
Gnomad FIN exome
AF:
0.250
Gnomad NFE exome
AF:
0.185
Gnomad OTH exome
AF:
0.188
GnomAD4 exome
AF:
0.196
AC:
286756
AN:
1461674
Hom.:
29561
Cov.:
33
AF XY:
0.197
AC XY:
143062
AN XY:
727138
show subpopulations
African (AFR)
AF:
0.0840
AC:
2813
AN:
33478
American (AMR)
AF:
0.269
AC:
12037
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.175
AC:
4576
AN:
26128
East Asian (EAS)
AF:
0.392
AC:
15548
AN:
39690
South Asian (SAS)
AF:
0.237
AC:
20463
AN:
86232
European-Finnish (FIN)
AF:
0.243
AC:
12968
AN:
53390
Middle Eastern (MID)
AF:
0.100
AC:
574
AN:
5738
European-Non Finnish (NFE)
AF:
0.186
AC:
206289
AN:
1111934
Other (OTH)
AF:
0.190
AC:
11488
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
12782
25564
38347
51129
63911
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7428
14856
22284
29712
37140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.178
AC:
27152
AN:
152224
Hom.:
2887
Cov.:
33
AF XY:
0.187
AC XY:
13884
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.0888
AC:
3689
AN:
41560
American (AMR)
AF:
0.229
AC:
3508
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.180
AC:
625
AN:
3470
East Asian (EAS)
AF:
0.407
AC:
2104
AN:
5174
South Asian (SAS)
AF:
0.250
AC:
1208
AN:
4824
European-Finnish (FIN)
AF:
0.266
AC:
2816
AN:
10596
Middle Eastern (MID)
AF:
0.109
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
0.188
AC:
12756
AN:
67988
Other (OTH)
AF:
0.175
AC:
369
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1111
2223
3334
4446
5557
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
300
600
900
1200
1500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.182
Hom.:
11601
Bravo
AF:
0.172
Asia WGS
AF:
0.298
AC:
1036
AN:
3478
EpiCase
AF:
0.171
EpiControl
AF:
0.172

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant pseudohypoaldosteronism type 1 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pseudohypoaldosteronism type 2D Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
11
DANN
Benign
0.54
PhyloP100
0.97
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2301708; hg19: chr5-136969793; COSMIC: COSV59051876; COSMIC: COSV59051876; API